Twist Bioscience’s $250 Million Common Stock Offering

Orrick, Herrington & Sutcliffe advised Twist Bioscience, while Latham & Watkins represented the underwriters in the offering.Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now